Kyongbo Pharmaceutical Co Ltd
KRX:214390
Kyongbo Pharmaceutical Co Ltd
KRX:214390
Price:
6 820
KRW
Market Cap:
₩163.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyongbo Pharmaceutical Co Ltd
Tax Provision
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Kyongbo Pharmaceutical Co Ltd
Tax Provision Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
Tax Provision
-₩267.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Tax Provision
-₩37.4B
|
CAGR 3-Years
-105%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Tax Provision
₩102.4B
|
CAGR 3-Years
223%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Tax Provision
-₩26.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
6%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Tax Provision
-₩487.7m
|
CAGR 3-Years
-77%
|
CAGR 5-Years
44%
|
CAGR 10-Years
17%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Tax Provision
-₩2.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Kyongbo Pharmaceutical Co Ltd
Glance View
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Asan, Chungcheongnam-Do. The company went IPO on 2015-06-29. The firm distributes its products within domestic market and to overseas markets including China Japan and Europe.
Intrinsic Value
9 219.39
KRW
Undervaluation 26%
See Also
What is Kyongbo Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
-267.2m
KRW
-267.2m
KRW
Based on the financial report for Dec 31, 2025, Kyongbo Pharmaceutical Co Ltd's Tax Provision amounts to -267.2m KRW.
What is Kyongbo Pharmaceutical Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
43%
43%
Over the last year, the Tax Provision growth was -1%.
